Minimal information for Chemosensitivity assays (MICHA): A next-generation pipeline to enable the FAIRification of drug screening experiments

Mostrar otras versiones (1)

Chemosensitivity assays are commonly used for preclinical drug discovery and clinical trial optimization. However, data from independent assays are often discordant, largely attributed to uncharacterized variation in the experimental materials and protocols. We report here the launching of MICHA (Mi...

Descripción completa

Detalles Bibliográficos
Autores principales: Tanoli, Ziaurrehman, Aldahdooh, Jehad, Alam, Farhan, Wang, Yinyin, Seemab, Umair, Fratelli, Maddalena, Pavlis, Petr, Hajduch, Marian, Bietrix, Florence, Gribbon, Philip, Zaliani, Andrea, Hall, Matthew D., Shen, Min, Brimacombe, Kyle, Kulesskiy, Evgeny, Saarela, Jani, Wennerberg, Krister, Vähä-Koskela, Markus, Tang, Jing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7724669/
https://www.ncbi.nlm.nih.gov/pubmed/33300000
http://dx.doi.org/10.1101/2020.12.03.409409

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7724669/
https://www.ncbi.nlm.nih.gov/pubmed/33300000
http://dx.doi.org/10.1101/2020.12.03.409409

Ejemplares similares